Related Experiment Videos

Heparin-coated cardiopulmonary bypass equipment. II. Mechanisms for reduced complement activation in vivo

V Videm1, T E Mollnes, K Bergh

  • 1Department of Surgery A, Institute for Surgical Research, Department of Anaesthesiology, and Department of Clinical Chemistry, The National Hospital, Oslo University, Oslo, Norway.

Insights

Heparin-coated cardiopulmonary bypass equipment reduced complement activation, specifically C3bc and terminal complement complex formation, during heart surgery. This suggests heparin coating is beneficial for mitigating complement-mediated inflammatory responses.

Area of Science:

  • Cardiovascular Surgery
  • Immunology
  • Biomaterials Science

Background:

  • Complement activation during cardiopulmonary bypass (CPB) can lead to inflammatory responses.
  • Heparin coating of CPB equipment is utilized to mitigate these effects.

Purpose of the Study:

  • To investigate the mechanisms by which heparin coating reduces complement activation during CPB.
  • To compare complement activation markers in patients undergoing CPB with heparin-coated versus uncoated equipment.

Main Methods:

  • Randomized trial comparing Duraflo II heparin-coated (n=15) versus uncoated (n=14) CPB sets in adult coronary artery bypass grafting patients.
  • Analysis of blood samples for complement activation products (C1rs-C1 inhibitor, Bb, C4bc, C3bc, C5a-desArg, terminal complement complex) using enzyme immunoassays.

Main Results:

  • Heparin coating increased C1 activation initially but significantly reduced C3bc and terminal complement complex formation (P=.03 and P<.01, respectively).
  • Bb and C5a-desArg tended to increase less with heparin coating (P=.22 and P=.13).
  • Terminal complement complex concentrations correlated with alternative pathway activation (Bb, C3bc).

Conclusions:

  • Heparin coating of CPB equipment effectively inhibits C3bc and terminal complement complex formation, despite initial C1 activation.
  • Terminal complement complex formation appears linked to alternative pathway activation and may serve as a marker for CPB circuitry differences.
  • The observed reduction in complement activation suggests a benefit of heparin-coated CPB equipment in clinical heart surgery.
Abstract

Related Concept Videos